5-HT(2a)/(2c) receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

Psychopharmacology

Volumn 126, Issue 1, 1996, Pages 24-30

  Coccaro, Emil F ^a   Kavoussi, Richard J ^a   Oakes, Michael ^a   Cooper, Thomas B ^b   Hauger, Richard ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5HT(2a 2c) receptor blockade; Amesergide; d Fenfluramine; Prolactin response

Indexed keywords

AMESERGIDE; DEXFENFLURAMINE; PROLACTIN; RITANSERIN; SEROTONIN 1C RECEPTOR; SEROTONIN 2A RECEPTOR; ERGOLINE DERIVATIVE; FENFLURAMINE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BLOCKING; VERTIGO; ANALYSIS OF VARIANCE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SECRETION;

ADULT; ANALYSIS OF VARIANCE; ERGOLINES; FENFLURAMINE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029662135     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246407     Document Type: Article

References (37)

1. Anderson IM, Cowen PJ, Grahame-Smith DG (1988) The effect of BRL 43694 on the neuroendocrine responses to L-tryptophan infusion. J Psychopharmacol 2:2
2. Ben-Jonathan N, Abbogast LA, Hyde JF (1989) Neuroendocrine regulation of prolactin release. Prog Neurobiol 33:399 447
3. 2 receptors. Hum Psychopharmacol 1:93-97
4. 1a receptors in impulsive aggressive behavior in humans. Psychopharm Bull 26:393-405
5. Coccaro EE (1992) Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavioral relationship, Int Clin Psychopharmacol 7:3-12
6. Coccaro EF, Kavoussi RJ (1994) The neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 40:319-327
7. 2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamcsergide in rats and rodents. J Pharm Pharmacol 46:226-229
8. 1c) receptors. J Pharmacol and Exp Ther 242: 552-557
9. Cowan PJ, Anderson IM (1985) 5-HT Neuroendocrinology: changes during depressive illness and antidepressant drug treatment. In: Deakin JEW (ed) The biology of depression. Gaskell, UK
10. Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A (1989) Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 162:371-373
11. Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ (1992) Preclinical studies on LY237733, a potent and selective serotonergic antagonist. J Pharmacol Exp Ther 260:51-57
12. Garattini S, Mennini T, Samanin R (1987) From fenfluramine racemate to d-fenfluramine: Specificty and potency of the effects on the serotonergic system and food intake. Ann NY Acad Sci 499:156-165
13. 2 receptor antagonist, on serotonin hand vein constriction in humans. Clin Pharmacol Ther 51:152
14. Goodall EM, Cowan PJ, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermal responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-466
15. 1 recognition sites. J Recep Res 8:59-81
16. 3 receptors in the mediation of the prolaction response to serotonin and 5-hydroxytryptoplian. Neuroendocrinology 55:336-343
17. Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, Van Praag HM (1990) Effects of serotonin antagonists on m-chlorophenylpiperazine-medialed responses in normal subjects. Psychiatry Res 33:189-198
18. Klein DN, Ouimette PC, Kelly HS, Ferro T, Riso LP (1994) Test-retest reliability of a team consensus best-estimate diagnoses of axis I and II disorders in a family study. Am J Psychiatry 151:1043-1047
19. Krebs HA, Chens LK, Wright GJ (1984) Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr 310:412-417
20. Kuhn CM, Vogel RA, Mailman RB, Mueller RA, Schanherg SM, Bresse GR (1981) Effect of 5, 7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology 73:188-193
21. Leckman JF, Sholomskus D, Thompson WD, Belanger A, Weissman MM (1982) Best estimate of lifetime psychiatric diagnosis: a methodologic study. Arch Gen Psychiatry 39:879-883
22. Lee MA, Nash F, Barnes M, Meltzer HY (1991) Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology 103:258-264
23. Lewis DA, Sherman BM (1985) Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinol 110:152-157
24. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Meyers JE, Stanley M (1992) Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 49: 442-446
25. McCance SL, Cowen PJ, Waller H, Grahame-Smith DG (1987) The effect of metergoline on endocrine responses to L-tryptophan. J Psychopharmacology 2:90-94
26. Meltzer HY, Maes M (1994) Effect of pindolol on the L-5-HTP-induced increase in palsma prolactin and cortisol concentrations in man. Psychopharmacology 114:635-643
27. Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry 41:379-387
28. Park SBG, Cowen PJ (1995) Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118:471-474
29. Pfohl B, Blum N, Zimmerman M, Stangl D (1989) Structured interview for the diagnosis of DSM-III-R personality disorders. University of Iowa College of Medicine
30. Quattrone A, DiRenzo G, Schettini G, Tedeschi G. Preziosi P (1979) Effect of midbrain raphe lesion or 5, 7-dihydroxylryptamine treatment on the prolactin-releasing action of quipazine and d-fenfluramine in rats. Brain Res 174:71-79
31. Quattrone A, Tedeschi G, Agugla F, Scopaeaso F, DiRenzo GF, Annuziato L (1983) Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 16:471-475
32. Siever LJ, Kahn RS, Lawlor BA, Trestman RL, Lawrence TL, Coccaro EF (1991) Critical issues in defining the role of serotonin in the psychiatric disorders. Pharmacol Rev 43:509-525
33. Simansky KJ, Schlechter LE (1988) Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents. J Pharmacol Exp Ther 247:1073-1081
34. Smith CE, Ware CJ, Cowen PJ (1991) Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology 103:140-142
35. Spitzer RL (1987) The diagnostic and statistical manual, 3rd edn revised (DSM-III-R). American Psychiatric Press, Washington, DC
36. Spitzer RL, Endicott J (1978) Schedule for affective disorders and Schizophrenia. NY State Psychiatric Institute. New York
37. 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanesthetized rat. Neuroendocrinology 47:83-87